Skip to content

Clinical trials

Diabetic Retinopathy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Retinopathy Clear all

682 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20015
20022
20034
20045
200512
200624
200722
200828
200920
201013
201119
201226
201317
201422
201525
201631
201723
201845
201936
202032
202144
202249
202330
202439
202546
202642

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed359
Unknown status123
Recruiting73
Terminated45
Not yet recruiting30
Active, not recruiting25
Withdrawn19
Enrolling by invitation8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Eye Institute (NEI)25
Association for Innovation and Biomedical Research on Light and Image16
University of Sao Paulo13
Novartis Pharmaceuticals11
Jaeb Center for Health Research9
Zhongshan Ophthalmic Center, Sun Yat-sen University9
Sun Yat-sen University7
University of Alabama at Birmingham7
University of Wisconsin, Madison7
Assiut University6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Retinopathy682
Diabetes Mellitus142
Macular Degeneration94
Macular Edema75
Retinal Diseases55
Glaucoma40
Retinal Vein Occlusion38
Diabetes Mellitus, Type 237
Diabetes Mellitus, Type 127
Cataract23

Trials

Showing 51 to 75 of 682. Each trial links to its page on Pharma Observatory.

582 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.